Susquehanna Maintains Neutral on Okta, Raises Price Target to $185
Goldman Sachs Maintains Buy on Okta, Raises Price Target to $203
Macquarie Maintains Outperform on Okta, Raises Price Target to $185
Citigroup Maintains Neutral on Okta, Raises Price Target to $165
JP Morgan Maintains Overweight on Okta, Raises Price Target to $190
Mizuho Maintains Neutral on Okta, Raises Price Target to $165
Raymond James Maintains Outperform on Okta, Raises Price Target to $185
B of A Securities Upgrades Okta to Neutral, Raises Price Target to $170
BMO Capital Maintains Outperform on Okta, Raises Price Target to $187
Jefferies Maintains Buy on Okta, Raises Price Target to $200
Baird Maintains Outperform on Okta, Raises Price Target to $185
Piper Sandler Maintains Neutral on Okta, Raises Price Target to $160
Canaccord Genuity Maintains Buy on Okta, Raises Price Target to $175
Okta Posts Q2 Beat, Analysts Raise Price Targets On Growing Agentic AI Opportunity
TD Cowen Maintains Hold on Okta, Raises Price Target to $175
Barclays Maintains Overweight on Okta, Raises Price Target to $180
Bernstein Maintains Outperform on Okta, Raises Price Target to $143
RBC Capital Maintains Outperform on Okta, Raises Price Target to $195
UBS Maintains Buy on Okta, Raises Price Target to $200
Oppenheimer Maintains Outperform on Okta, Raises Price Target to $190
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.